COVID - 19 Vaccination Update - Day 593 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 40 Second

Posted On: 31 AUG 2022 8:39PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 212.50 Crore (2,12,50,89,814) today. More than 10 lakh (10,01,872) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10414095
	2^nd Dose	10106601
	Precaution Dose	6759254
FLWs	1^st Dose	18434602
	2^nd Dose	17698817
	Precaution Dose	13156276
Age Group 12-14 years	1^st Dose	40339990
	2^nd Dose	30231478
Age Group 15-18 years	1^st Dose	61684755
	2^nd Dose	52345939
Age Group 18-44 years	1^st Dose	560601363
	2^nd Dose	513139322
	Precaution Dose	63265124
Age Group 45-59 years	1^st Dose	203906553
	2^nd Dose	196327765
	Precaution Dose	35386868
Over 60 years	1^st Dose	127581775
	2^nd Dose	122716301
	Precaution Dose	40992936
Cumulative 1^st dose administered		1022963133
Cumulative 2^nd dose administered		942566223
Precaution Dose		159560458
Total		2125089814

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 31^st August, 2022 (593^rd Day)
HCWs	1^st Dose	19
	2^nd Dose	109
	Precaution Dose	4840
FLWs	1^st Dose	34
	2^nd Dose	219
	Precaution Dose	9269
Age Group 12-14 years	1^st Dose	16548
	2^nd Dose	26318
Age Group 15-18 years	1^st Dose	5404
	2^nd Dose	16306
Age Group 18-44 years	1^st Dose	14373
	2^nd Dose	49708
	Precaution Dose	516858
Age Group 45-59 years	1^st Dose	2256
	2^nd Dose	10274
	Precaution Dose	218433
Over 60 years	1^st Dose	1239
	2^nd Dose	6843
	Precaution Dose	102822
Cumulative 1^st dose administered		39873
Cumulative 2^nd dose administered		109777
Precaution Dose		852222
Total		1001872

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.